发明名称 切迫妊娠高血圧腎症および/またはHELLP症候群の指標としてのsFlt−1またはエンドグリン/PlGF比の動態
摘要 Diagnostic methods and tools relating to diagnosing whether a pregnant subject is at risk for developing preeclampsia and/or early-onset preeclampsia within a short period of time. The methods include determining the amounts of the biomarkers sFlt-1 or Endoglin and PIGF in a first and a second sample of said subject, said first sample being obtained prior to said second sample; calculating a first ratio from the amounts of sFlt-1 or Endoglin and PIGF determined in the first sample, and a second ratio from the amounts of sFlt-1 or Endoglin and PIGF determined in the second sample; and comparing the value of the first and the second ratio, whereby a subject being at risk for developing preeclampsia within a short period of time is diagnosed if the value of the second ratio is increased compared to the value of the first ratio by a factor of at least about 3.
申请公布号 JP6034394(B2) 申请公布日期 2016.11.30
申请号 JP20140540463 申请日期 2012.11.08
申请人 エフ.ホフマン−ラ ロシュ アーゲーF. HOFFMANN−LA ROCHE AKTIENGESELLSCHAFT 发明人 デンク,バルバラ;フント,マルティン
分类号 G01N33/68;G01N33/53;G01N33/573 主分类号 G01N33/68
代理机构 代理人
主权项
地址